@article{df109441-3e5f-4735-904c-df069f79009b,
  abstract     = {{<p>BACKGROUND: It is now possible to acquire a fully diagnostic standard 12-lead electrocardiography (ECG) using a smartwatch, a smartphone app, and no additional hardware. This study aims to evaluate the predictive performance of advanced ECG (A-ECG) analysis applied to a smartwatch 12-lead ECG (SWECG) acquired using an Apple Watch in identifying cardiovascular risks among asymptomatic adults performing consumer self-screening in the general population.</p><p>METHODS AND DESIGN: The Heart Watch Study is a prospective, Australia-wide observational cohort study. The study will recruit 30,000 participants aged 20-79 years without prior known cardiovascular disease. Participants will enrol and consent electronically, and download a dedicated study iPhone app that enables a directed 12-lead SWECG acquisition using an Apple Watch. The recordings will undergo both conventional and A-ECG analysis. Follow-up will be performed through linkage with administrative health datasets in Australia, including hospital visits and mortality. The primary combined endpoint is all-cause mortality, hospitalization for cardiovascular causes, and incident cardiovascular disease (arrythmia, ischemic heart disease, heart failure) as predicted by existing A-ECG analyses.</p><p>CONCLUSION: This study evaluates the feasibility of performing a fully diagnostic standard 12-lead SWECG using only a smartwatch and a smartphone application, and addresses the prognostic value of A-ECG machine-learning based analysis in consumer self-screening in a large, diverse and apparently healthy population.</p>}},
  author       = {{Al-Falahi, Zaidon S and Schlegel, Todd T and Lee, Vivian and Chow, Clara K and Kozor, Rebecca and Lindow, Thomas and Ugander, Martin}},
  issn         = {{1097-6744}},
  language     = {{eng}},
  month        = {{09}},
  publisher    = {{Mosby-Elsevier}},
  series       = {{American Heart Journal}},
  title        = {{Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead ECG with advanced ECG analysis in consumer self-screening for cardiovascular disease}},
  url          = {{http://dx.doi.org/10.1016/j.ahj.2026.107619}},
  doi          = {{10.1016/j.ahj.2026.107619}},
  year         = {{2026}},
}

